Table 4a.
Ganglion cell layer-inner plexiform layer thickness in diabetic patients and control (n=180)
| GCL-IPL thickness (µM) | Diabetic eyes (n=120), mean (SD) | Control eyes (n=60), mean (SD) | P* | |
|---|---|---|---|---|
|
| ||||
| With retinopathy (n=60) | Without retinopathy (n=60) | |||
| Superior | 71.6 (3.0) | 82.9 (2.3) | 92.3 (2.2) | <0.001 |
| Superonasal | 71.2 (2.8) | 82.6 (2.2) | 91.9 (2.5) | <0.001 |
| Superotemporal | 71.7 (2.7) | 82.6 (2.0) | 92.5 (2.4) | <0.001 |
| Inferior | 71.4 (3.0) | 82.1 (2.5) | 91.9 (2.7) | <0.001 |
| Inferonasal | 71.9 (2.5) | 83.2 (1.9) | 91.9 (2.4) | <0.001 |
| Inferotemporal | 71.5 (2.5) | 82.5 (2.6) | 92.6 (2.3) | <0.001 |
*One way ANOVA. GCL-IPL: Ganglion cell layer-inner plexiform layer, SD: Standard deviation